China's marketing authorization holder mechanism is now being expanded to the medtech sector, and from the original four mega cities to 21 provinces, including the major medtech-producing provinces, Jiangsu, Zhejiang and Shandong.
International device makers can also leverage the MAH mechanism, which is a method of contracting manufacturing to local companies, which will reduce costs.